Isolation of a small molecule with anti-MRSA activity from a mangrove symbiont Streptomyces sp. PVRK-1 and its biomedical studies in Zebrafish embryos

Asian Pacific Journal of Tropical Biomedicine

Volumn 1, Issue 5, 2011, Pages 341-347

  Kannan, Rajaretinam Rajesh ^a   Iniyan, Appadurai Muthamil ^b   Prakash, Vincent Samuel Gnana ^a  

^a MANONMANIAM SUNDARANAR UNIVERSITY   (India)

^b Xpression Biotek (Pvt) Ltd   (India)

Author keywords

Biochemial study; Cardiac assay; Mangrove; Methicillin resistant; Minimal inhibitory concentration; Organogenesis; RP HPLC; Small molecule; Staphylococcus aureus; Streptomyces; Zebrafish embryo

Indexed keywords

ANTIINFECTIVE AGENT; SMALL MOLECULE A2; UNCLASSIFIED DRUG;

16S RRNA GENE; ANALYTICAL PARAMETERS; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CARDIOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG PURIFICATION; DRUG SYNTHESIS; EMBRYO; EMBRYOTOXICITY; GENE AMPLIFICATION; HEART BEAT; HEART RATE; LC 50; MANGROVE; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGANOGENESIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PUS; RETENTION TIME; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RF VALUE; RNA GENE; RNA SEQUENCE; SOLID STATE FERMENTATION; STREPTOMYCES; SYMBIONT; THIN LAYER CHROMATOGRAPHY; TOXICITY TESTING; ZEBRA FISH; ANIMAL; ANIMAL EMBRYO; CHEMISTRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOLOGY; RHIZOPHORACEAE; TOXICITY;

ANIMALS; ANTI-BACTERIAL AGENTS; EMBRYO, NONMAMMALIAN; HEART RATE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; RHIZOPHORACEAE; STREPTOMYCES; ZEBRAFISH;

EID: 83455238370     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(11)60077-4     Document Type: Article

References (41)

1. Sakoulas G, Moellering RC Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis 2008, 46(Suppl 5):S360-S367.
2. Deurenberg RH, Stobberingh EE The evolution of Staphylococcus aureus. Infect Genet Evol 2008, 8(6):747-763.
3. European antimicrobial resistance surveillance system. EARSS annual report 2008. Bilthoven: earess; 2009.
4. Campanile F, Bongiorno D, Borbone S, Stefani S Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy. Ann Clin Microbiol Antimicrob 2009, 8:22.
5. Hope R, Livermore DM, Brick G, Lillie M, Reynolds R BSAC working parties on resistance surveillance: non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008, 62(Suppl 2):ii65-ii74.
6. Valentini P, Parisi G, Monaco M, Crea F, Spanu T, Ranno O, et al. An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report. Ann Clin Microbiol Antimicrob 2008, 7:11.
7. Stefani S, Bongiorno D, Cafiso V, Campanile F, Crapis M, Cristini F, et al. Pathotype and susceptibility profile of a community-acquired methicillin-resistant Staphylococcus aureus strain responsible for a case of severe pneumonia. Diagn Microbiol Infect Dis 2009, 63(1):100-104.
8. Asad UK, Ayesha S, Anju T, Shazia Z, Mohd A, Sukhminderjit K, et al. Amplification of mecA gene in multi-drug resistant Staphylococcus aureus strains from hospital personnel. J Infect Dev Ctries 2007, 1(3):289-295.
9. Chambers HF The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 2001, 7:178-182.
10. Tiwari HK, Sen MR Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis 2006, 6:156.
11. Demain AL Antibiotics: Natural products essential to human health. Med Res Rev 2009, 29(6):821-842.
12. Yoo JC, Kim JH, Ha JW, Park NS, Sohng JK, Lee JW, et al. Production and biological activity of Laidomycin, Anti MRSA/VRE antibiotic from Streptomyces sp. CS684. J Microbiol 2007, 45(1):6-10.
13. Chakraborty SP, Mahapatra SK, Roy S Biochemical characters and antibiotic susceptibility of Staphylococcus aureus isolates. Asian Pac J Trop Biomed 2011, 212-216.
14. Astrid MV, Appelmelk BJ, Christina MJE, Vandenbroucke G, Bitter W A star with stripes: Zebrafish as an infection model. Trends in Microbiology 2004, 12(10):451-457.
15. Bretaud S, Lee S, Guo S Sensitivity of Zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol Teratol 2004, 26:857-864.
16. Hill AJ, Teraoka H, Heideman W, Peterson RE Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005, 86:6-19.
17. Rajaretinam RK, Vincent SGP Isolation of a novel bioactive compound from Rhizophora mucronata for methicillin resistant Staphylococcus aureus (MRSA) and compound toxicity assessment in Zebra fish embryos. J Pharm Res 2010, 3(8):2000-2003.
18. Kannan RR, Vincent SGP Molecular characterization of antagonistic Streptomyces isolated from a mangrove swamp. Asian J Biotechnol 2011, 3:237-245.
19. Gauthier MJ, Shewan JM, Gibson DM Taxonomic position and seasonal variations in marine neritic environment of some Gram-negative antibiotic-producing bacteria. J Microbiol 1975, 87:211-218.
20. Jensen PR, Williams PG, Oh DC, Zeigler L, Fenical W Species-specific secondary metabolite production in marine actinomycetes of the genus Salinispora. Appl Environ Microbiol 2007, 73(4):1146-1152.
21. Wagner H, Bladt W Plant Drug Analysis. A thin layer chromatography atlas 1996, Springer-Verlag, Birlin. 2nd edi.
22. Kim S, Oh KB Evaluation of antimicrobial activity of farnesoic acid derivatives. J Microbiol Biotchnol 2002, 12:1006-1009.
23. Westerfield M The Zebrafish book. A Guide for the laboratory use of Zebrafish Danio rerio 1989, University of Oregon Press, Eugene.
24. Latha SP, Kannabiran K Antimicrobial activity and phytochemicals of Solanum trinobatum Linn. Afr J Biotechnol 2006, 5(23):2402-2404.
25. Bhimba BV, Meenupriya J, Joel EL, Naveena DE, Kumar S, Thangaraj M Antibacterial activity and characterization of secondary metabolites isolated from mangrove plant Avicennia officinalis. Asian Pac J Trop Med 2010, 3(7):544-546.
26. Moghadam MS, Maleki S, Darabpour E, Motamedi H, Nejad SMS Antibacterial activity of eight Iranian plant extracts against methicillin and cefixime restistant Staphylococcous aureus strains. Asian Pac J Trop Med 2010, 3(4):262-265.
27. Rasheed MU, Ahmed Z Phenotypic methods of greater accuracy to detect the mecA gene product for the recognition of MRSA in resource constraint settings. Asian Pac J Trop Med 2010, 3(9):741-744.
28. Jarrar N, Abu-Hijleh A, Adwan K Antibacterial activity of Rosmarinus officinalis L. alone and in combination with cefuroxime against methicillin-resistant Staphylococcus aureus. Asian Pac J Trop Med 2010, 3(2):121-123.
29. Gould FK, Brindle R, Chadwick PR Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother 2009, 63:849-861.
30. Fenical W, Jensen PR Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol 2006, 2:666-673.
31. Kwon HC, Kauffman CA, Jensen PR, Fenical W Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus " marinispora" J Am Chem Soc 2006, 128:1622-1632.
32. Hughes CC, Prieto-Davo A, Jensen PR, Fenical W The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. Org Lett 2008, 10:629-631.
33. McArthur KA, Mitchell SS, Tsueng G, Rheingold A, White DJ, Grodberg J, et al. Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete. J Nat Prod 2008, 71:1732-1737.
34. Barros TP, Alderton WK, Reynolds HM, Roach AG, Berghmans S Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br J Pharmacol 2008, 154:1400-1413.
35. Haste NM, Perera V, Maloney KN, Tran DN, Jensen P, Fenical W, et al. Activity of the streptogramin antibiotic etamycin against methicillin-resistant Staphylococcus aureus. J Antibiot 2010, 63(5):219-224.
36. Murphey RD, Zon LI Small molecule screening in the Zebrafish. Methods 2006, 39:255-261.
37. Patricia M, Chun QL Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today 2008, 13:9-10.
38. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TT Stages of embryonic development of the Zebrafish. Dev Dyn 1995, 203:253-310.
39. Thisse C, Zon L Organogenesis - heart and blood formation from the Zebrafish point of view. Science 2002, 295:457-462.
40. Stainier DY, Fouquet B, Chen JN, Warren KS, Weinstein BM, Meiler SE, et al. Mutations affecting the formation and function of the cardiovascular system in the Zebrafish embryo. Development 1996, 123:285-292.
41. Peterson RT, Mably JD, Chen JN, Fishman MC Convergence of distinct pathways to heart patterning revealed by the small molecule concentramide and the mutation heart-and-soul. Curr Biol 2001, 11:1481-1491.